Literature DB >> 26279148

Venous access: the patient experience.

Melissa Robinson-Reilly1, Penny Paliadelis2, Mary Cruickshank3.   

Abstract

INTRODUCTION: The evolution of venous access via peripheral cannulation, particularly in relation to the risks and the benefits of this procedure, is reported widely in the literature. However, there is limited research specific to the patient experience of undergoing venous access. AIM: The intent of this qualitative study was to understand patients' experience of venous access, with the aim of bringing forth their voices about the experiences of repeated venous access/cannulation attempts.
METHODOLOGY: This qualitative study used a hermeneutic phenomenological approach to explore the experiences of 15 participants in two rural oncology units in Australia. The participants had experienced repeated peripheral cannulation in order to receive chemotherapy. Study participants were asked to describe what it was like for them to be repeatedly cannulated. Data were collected via audiotaped individual interviews, the participants' stories were transcribed and analysed thematically. OUTCOMES: Themes emerged from the participants' stories that provided insights into their perceptions of the experience of being cannulated and the decision-making processes regarding how and where the procedure occurred. The findings suggest that a holistic approach to care was often missing causing the participants to feel vulnerable. Gaining insight into their experiences led to a greater understanding of the impact of this procedure on patients and the need to improve care through encouraging more collaborative decision-making processes between clinicians and patients.
CONCLUSION: The implications for policy and practice focus on improving patient outcomes via procedural governance and education, with the intent of translating the findings from this research into evidence-based practice.

Entities:  

Keywords:  Cannulation; Paternalism; Patient-centred; Qualitative; Venous access; Vulnerability

Mesh:

Year:  2015        PMID: 26279148     DOI: 10.1007/s00520-015-2900-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  13 in total

1.  Receiving bad news: a phenomenological exploration of the lived experience of receiving a cancer diagnosis.

Authors:  Gerard A Tobin; Cecily Begley
Journal:  Cancer Nurs       Date:  2008 Sep-Oct       Impact factor: 2.592

2.  The history of intravenous therapy.

Authors:  D Millam
Journal:  J Intraven Nurs       Date:  1996 Jan-Feb

3.  Towards an understanding of nursing as a response to human vulnerability.

Authors:  Derek Sellman
Journal:  Nurs Philos       Date:  2005-01       Impact factor: 1.279

Review 4.  Controversies in oncologist-patient communication: a nuanced approach to autonomy, culture, and paternalism.

Authors:  Nathan I Cherny
Journal:  Oncology (Williston Park)       Date:  2012-01       Impact factor: 2.990

5.  Developing a Research base for Intravenous Peripheral cannula re-sites (DRIP trial). A randomised controlled trial of hospital in-patients.

Authors:  Joan Webster; Sophia Lloyd; Tracey Hopkins; Sonya Osborne; Maria Yaxley
Journal:  Int J Nurs Stud       Date:  2006-03-30       Impact factor: 5.837

6.  Who speaks for the vulnerable?

Authors:  Judith A Erlen
Journal:  Orthop Nurs       Date:  2006 Mar-Apr       Impact factor: 0.913

7.  Toward patient-centered cancer care: patient perceptions of problematic events, impact, and response.

Authors:  Kathleen M Mazor; Douglas W Roblin; Sarah M Greene; Celeste A Lemay; Cassandra L Firneno; Josephine Calvi; Carolyn D Prouty; Kathryn Horner; Thomas H Gallagher
Journal:  J Clin Oncol       Date:  2012-04-16       Impact factor: 44.544

8.  Blood transfusion: the patient's experience.

Authors:  Kristine Weiss Adams; Deborah Tolich
Journal:  Am J Nurs       Date:  2011-09       Impact factor: 2.220

9.  Shared decision making or paternalism in nursing consultations? A qualitative study of primary care asthma nurses' views on sharing decisions with patients regarding inhaler device selection.

Authors:  Jane Upton; Monica Fletcher; Hazel Madoc-Sutton; Aziz Sheikh; Ann-Louise Caress; Samantha Walker
Journal:  Health Expect       Date:  2011-02-16       Impact factor: 3.377

10.  Preferences of acutely ill patients for participation in medical decision-making.

Authors:  C Wilkinson; M Khanji; P E Cotter; O Dunne; S T O'Keeffe
Journal:  Qual Saf Health Care       Date:  2008-04
View more
  6 in total

1.  Patients' Perspectives on the Quality and Safety of Intravenous Infusions: A Qualitative Study.

Authors:  Carly Wheeler; Dominic Furniss; Galal H Galal-Edeen; Ann Blandford; Bryony Dean Franklin
Journal:  J Patient Exp       Date:  2019-04-30

2.  A clinical pathway for the management of difficult venous access.

Authors:  Vanno Sou; Craig McManus; Nicholas Mifflin; Steven A Frost; Julie Ale; Evan Alexandrou
Journal:  BMC Nurs       Date:  2017-11-17

3.  Protocol for a systematic review and thematic synthesis of patient experiences of central venous access devices in anti-cancer treatment.

Authors:  Caoimhe Ryan; Hannah Hesselgreaves; Olivia Wu; Jim Paul; Judith Dixon-Hughes; Jonathan G Moss
Journal:  Syst Rev       Date:  2018-04-18

4.  Patient acceptability of three different central venous access devices for the delivery of systemic anticancer therapy: a qualitative study.

Authors:  Caoimhe Ryan; Hannah Hesselgreaves; Olivia Wu; Jonathan Moss; James Paul; Judith Dixon-Hughes; Evi Germeni
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

5.  Not "just" an intravenous line: Consumer perspectives on peripheral intravenous cannulation (PIVC). An international cross-sectional survey of 25 countries.

Authors:  Marie Cooke; Amanda J Ullman; Gillian Ray-Barruel; Marianne Wallis; Amanda Corley; Claire M Rickard
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

6.  Patients knowledge and experience with urinary and peripheral intravenous catheters.

Authors:  Bart J Laan; Pythia T Nieuwkerk; Suzanne E Geerlings
Journal:  World J Urol       Date:  2019-01-24       Impact factor: 4.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.